1 completed, 1 withdrawn. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Renova Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AC6 Gene Transfer in Patients With Reduced Left Ventricular Ejection Fraction Heart Failure Ad5.hAC6, Placebo - Heart Failure | Phase 3 | Withdrawn | Renova Therapeutics | 2019-06-01 | 2019-06-07 | |
| AC6 Gene Transfer for CHF Ad5.hAC6, Sucrose (3%) - Congestive Heart Failure | Phase 1 / Phase 2 | Completed | Hammond, H. Kirk, M.D. | 56 | 2010-07-01 | 2018-02-09 |
Heart Failure (2) · Adenoviridae Infections (1)
Sucrose (2)
United States (1)
Amit Patel, MD (1) · Clyde W Yancy, MD (1) · David R Murray, MD (1) · Eric D Adler, MD (1) · H. Kirk Hammond, MD (1) · Jay H Traverse, MD (1) · Matthew W Watkins, MD (1) · William Penny, MD (1)
P01HL066941 (1)